(Q38161850)

30 August 2017

title

Selective MAO-B inhibitors: a lesson from natural products (English)

1 reference

30 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Daniela Secci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Melissa D'Ascenzio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Paola Chimenti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Adriana Bolasco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

12 November 2013

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

219-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218136%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11030-013-9490-6

6 June 2020

exact match

0 references

cites work

Substrate-selective monoamine oxidases—inhibitor, tissue, species and functional differences

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inactivation: from pathophysiology to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

A review of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The therapeutic potential of monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase, brain ageing and degenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Molecular characterization of monoamine oxidases A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Focusing on new monoamine oxidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Natural products as leads to potential drugs: an old process or the new hope for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Natural products as sources of new drugs over the last 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The role of natural product chemistry in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Natural product guided compound library development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Herbal natural products as a source of monoamine oxidase inhibitors: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Dietary inhibitors of monoamine oxidase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Antidepressant-like effect of icariin and its possible mechanism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitory components from Cayratia japonica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitory components from the roots of Sophora flavescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitors from Gentiana lutea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Evaluation of the inhibitory effects of quercetin-related flavonoids and tea catechins on the monoamine oxidase-A reaction in mouse brain mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitory constituents from the fruits of Cudrania tricuspidata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Prenylated xanthones from the root bark of Cudrania tricuspidata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Isolation of the MAO-inhibitor naringenin from Mentha aquatica L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

In silico target fishing for the potential targets and molecular mechanisms of baicalein as an antiparkinsonian agent: discovery of the protective effects on NMDA receptor-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Xanthones from Gentianella amarella ssp. acuta with acetylcholinesterase and monoamine oxidase inhibitory activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase-inhibiting activity of mangiferin isolated fromCanscora decussata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Antidepressant-like effect of low molecular proanthocyanidin in mice: involvement of monoaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Catalpol protects mesencephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine Oxidase and Dopamine β-Hydroxylase Inhibitors from the Fruits of Gardenia jasminoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase B inhibitors from the fruits of Opuntia ficus-indica var. saboten

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The effects of curcumin on depressive-like behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Antidepressant activity of curcumin: involvement of serotonin and dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

An improved fluorimetric assay for brain monoamine oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitory activities of the scorpion Mesobuthus gibbosus (Buthidae) venom peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitory activities of indolylalkaloid toxins from the venom of the colonial spider Parawixia bistriata: functional characterization of PwTX-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Isolation and chemical characterization of PwTx-II: a novel alkaloid toxin from the venom of the spider Parawixia bistriata (Araneidae, Araneae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Quinolone alkaloids from evodiae fructus and their inhibitory effects on monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

1-methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

A rapid microfluorimetric determination of monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Methylpiperate derivatives from Piper longum and their inhibition of monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Berberine: a potential multipotent natural product to combat Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

On the mechanism of antidepressant-like action of berberine chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibitors from rhizoma of Coptis chinensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Platelet monoamine oxidase activity in alcoholics, alcoholics with drug dependence, and cocaine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Inhibition of monoamine oxidase activity by cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Antidepressant activity of Asparagus racemosus in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Asparagus racemosus competitively inhibits in vitro the acetylcholine and monoamine metabolizing enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibition by Rhodiola rosea L. roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The interactions of caffeine with monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Structure Determination of Hydroxytrypargine: A New Tetrahydro-?-Carboline Toxin from the Venom of the SpiderParawixia bistriata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

Monoamine oxidase inhibition by southern African traditional medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9490-6

A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates

21 January 2018

1 reference

12 December 2020

AN AMINE OXIDASE IN NORMAL HUMAN SERUM

1 reference

12 December 2020

Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-?-carboline administration in mice

1 reference

12 December 2020

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

12 December 2020

Quercetin as the Active Principle ofHypericumhircinumExerts a Selective Inhibitory Activity against MAO-A: Extraction, Biological Analysis, and Computational Study

1 reference

12 December 2020

Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem

1 reference

12 December 2020

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

12 December 2020

Inhibitory effects of the extract of pilose antler on monoamine oxidase in aged mice

1 reference

12 December 2020

Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinson's disease in mice.

1 reference

12 December 2020

Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N′-bis[2-oxo-2H-benzopyran]-3-carboxamides

1 reference

12 December 2020

Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria

1 reference

12 December 2020

The effect of age on the activity and molecular properties of human brain monoamine oxidase

1 reference

12 December 2020

[Inhibitory effect of hypoxanthine on monoamine oxidase activity]

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.

1 reference

12 December 2020

The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species

1 reference

12 December 2020

The inactivation of adrenaline

1 reference

12 December 2020